Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives

被引:141
作者
Ali, Mohamed Ashraf [1 ]
Shaharyar, Mohammad [1 ]
Siddiqui, Anees Ahamed [1 ]
机构
[1] Jamia Hamdard, Fac Pharm, Dept Pharmaceut Chem, New Delhi 110062, India
关键词
pyrazoline; isothiocyanate; anti-tubercular; Mycobacterium tuberculosis;
D O I
10.1016/j.ejmech.2006.08.004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the present investigation, a series of 5+4-(substituted) phenyl)-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-IH-1-pyrazolyl-2-toluidino methane thione and 5-(substituted) phenyl-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolyl-2-methoxyanilino methane thione were synthesized by the reaction between hydrazine hydrate and chalcones (3a-k) followed by condensation with appropriate aryl isothiocyanate which yielded N-substituted pyrazoline derivatives. Newly synthesized compounds were tested for their in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system. Among the synthesized compounds, compound anilino-3-(4-hydroxy-3-methylphenyl)-5-(2,6-dichlorophenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione (6i) was found to be more active agent against M. tuberculosis H37Rv with minimum inhibitory concentration of 0.0034 mu M. (c) 2006 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:268 / 275
页数:8
相关论文
共 12 条
[1]   TUBERCULOSIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BARNES, PF ;
BLOCH, AB ;
DAVIDSON, PT ;
SNIDER, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (23) :1644-1650
[2]   PLASMA HYDRAZINE CONCENTRATIONS IN MAN AFTER ISONIAZID AND HYDRALAZINE ADMINISTRATION [J].
BLAIR, IA ;
TINOCO, RM ;
BRODIE, MJ ;
CLARE, RA ;
DOLLERY, CT ;
TIMBRELL, JA ;
BEEVER, IA .
HUMAN TOXICOLOGY, 1985, 4 (02) :195-202
[3]  
Colins L., 1997, ANTIMICROB AGENTS CH, V41, P1004
[4]   A continuing survey of drug-resistant tuberculosis, New York City, April 1994 [J].
Fujiwara, PI ;
Cook, SV ;
Rutherford, CM ;
Crawford, JT ;
Glickman, SE ;
Kreiswirth, BN ;
Sachdev, PS ;
Osahan, SS ;
Ebrahimzadeh, A ;
Frieden, TR .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (05) :531-536
[5]  
INTERLEID B, 1991, ANTIBIOTIC LAB MED, P134
[6]   Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents [J].
Küçükgüzel, SG ;
Rollas, S .
FARMACO, 2002, 57 (07) :583-587
[7]  
Küçükgüzel SG, 2000, EUR J MED CHEM, V35, P761
[8]  
Nauduri D, 1998, CHEM PHARM BULL, V46, P1254, DOI 10.1248/cpb.46.1254
[9]   The need for new drugs against tuberculosis - Obstacles, opportunities, and next steps [J].
O'Brien, RJ ;
Nunn, PP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (05) :1055-1058
[10]   'Multidrug'-resistant tuberculosis - It is time to focus on the private sector of medicine [J].
Sbarbaro, JA .
CHEST, 1997, 111 (05) :1149-1151